At a House Oversight Committee hearing on Wednesday, former FDA Commissioner Dr. David Kessler fired back at Rep. Marjorie Taylor Greene (R-GA) over her claims about vaccines.
Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:
https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript
Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com
Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:
https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript
Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com
Category
🗞
NewsTranscript
00:00Madam Chair, may I please respond?
00:02No, this is my time, Dr. Kessler, and my time has expired.
00:06So I now recognize the ranking mem-
00:10Oh, Mr. Min has made it.
00:12I now recognize Mr. Min from California for five minutes.
00:15I'd like to hear Dr. Kessler's response to that last question.
00:18Thank you so much, Congressman.
00:21I am a pediatrician here,
00:24and it just is very important to state
00:29there is no scientific link between vaccines and autism.
00:35Respectfully, on the issue on VAERS,
00:40VAERS is an open reporting system,
00:44and you have to look and ask the question.
00:48You have to apply scientific principles-
00:50Selection bias, things like that.
00:52Bradford Hill, you're there, Congressman.
00:55Facts are facts, data is data,
00:57and a random website is not necessarily the best way to get any kind of real data.
01:02And we all understand, Dr. Kessler, the importance of peer review, don't we?
01:06Exactly.
01:07We have to-
01:09The issue, just because you see a reaction in a database,
01:12you have to ask whether there's causation.
01:15There are certain Bradford Hill principles that have to be applied,
01:18and they were not being applied.
01:19And it's unfortunate right now that science is being rejected by people going on Google,
01:24going on websites of dubious origin to try to find their own information.
01:28We should all be concerned about that.
01:30So I want to address-
01:31First, I want to thank the Chair and the Ranking Member for holding this hearing on the FDA.
01:35It is, as we know, the gold standard in the world for drug and medical product regulation.
01:40Its critical work has included the regulation and approval of a wide range of products,
01:45ranging from the drugs we consume to the formulas that we feed our children,
01:49and, of course, plays a crucial role in cracking down on counterfeit medical products and drugs.
01:54That is why I believe the FDA should be fully funded and independent.
01:59It is absolutely essential, particularly today, to ensure a safe supply chain
02:03and that our products that we consume for our health have been properly reviewed for market.
02:08Now, under the leadership, quote-unquote, of current HHS Secretary Kennedy and Donald Trump,
02:15the great public health apparatus is in the process of firing thousands of workers at HHS, NIH, and the FDA.
02:23FDA has seen proposals to slash 20 percent of its workforce,
02:29including 170 of those from the Office of Inspections and Investigations.
02:33And I just want to note that when we talk about efficiency, that's a word that gets thrown around a lot.
02:37We have to actually talk about what we mean when we talk about efficiency.
02:41What is the time frame we're looking at?
02:42What are the goals and parameters we want?
02:44If I want to lose weight, the fastest way to do that is maybe just cut off my leg.
02:49That is not an efficient way, if you're thinking beyond the immediate term,
02:52and one can argue that the cuts to FDA are having a similar effect.
02:56In particular, I want to talk about the effects on the drug approval pipeline.
03:03And so my understanding, Dr. Kessel, I think you're in a position to answer this,
03:06that I've been told by a lot of the life sciences companies that I represent in Orange County, California,
03:12that many of those drug approval people are actually paid for by user fees.
03:16Is that your understanding?
03:19Cedar has resources that are paid for by user fees,
03:24but that does not guarantee that the application will be approved.
03:28Of course. No, and that's not the point.
03:29Just make sure that there are people there who can review them.
03:32And so I think the point I would like to make here is that by cutting these people,
03:37by terminating staff, you are creating potentially a much longer pipeline for drug approval, product approval.
03:44That is something that a lot of the companies I represent, including companies like Edwards Life Sciences and Massimo,
03:50some of the pharmaceutical companies I represent are very concerned that they're going to see much longer approval processes.
03:56And again, these are positions that are paid for out of the user fees.
03:59They actually don't cost the taxpayer anything.
04:01And so when we look at efficiency beyond the anything but the immediate term,
04:05these cuts look very counterproductive.
04:07They look like they're going to have massive negative economic impacts on our communities, on the drug pipeline.
04:13And so I guess for you, Dr. Kessler, I just want to go back to you.
04:16How do you think drug approval times may be affected by cutting a blanket cut of 20 percent of the workforce?
04:21I think that drug approval times will increase, but most importantly,
04:26important medicines that we will depend on for our families.
04:30Those, that's what I care about.
04:33That's right.
04:33Life-saving medications are not going to get approved now.
04:36Or will take longer to approve.
04:37I hope not.
04:39There are still dedicated people, but I fear that those delays are going to happen.
04:44And when we talk about efficiency, I just want to note another thing that's happening right now.
04:48The attacks on immigrants, particularly in higher education,
04:52the cuts to NIH are having massive impacts on universities around the country,
04:56including UC Irvine, which I represent.
04:58They're very worried.
04:59I know that many of the immigrants that are researching are potentially groundbreaking efforts
05:05in new life sciences products and drugs that they, many of them are going back to their countries of origin.
05:12They're going to other countries and other top research institutions.
05:15I just want to ask them, it's my last question, Dr. Kessler,
05:18if you can speak about the administration's immigration actions
05:20and how you anticipate they might affect our life sciences industry here in the United States.
05:24Our competitiveness was enhanced by those people coming to universities in your district.
05:30They made America great.
05:31Exactly.
05:32And now we are driving around.
05:33The gentleman's time is inspired.
05:35Thank you. I get back.